Solid Biosciences Stock (NASDAQ: SLDB) stock price, news, charts, stock research, profile.
Open | $9.130 |
Close | - |
Volume / Avg. | 93.258K / 268.191K |
Day Range | 8.660 - 9.335 |
52 Wk Range | 1.810 - 15.050 |
Market Cap | $349.629M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 3.35% |
Days to Cover | 2.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: Renovaro (NASDAQ:RENB), Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG), Tevogen Bio Holdings (NASDAQ:TVGN) and Anika Therapeutics (NASDAQ:ANIK).
The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by William Blair on Thursday, March 28, 2024. The analyst firm set a price target for 40.00 expecting SLDB to rise to within 12 months (a possible 331.97% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $9.26 last updated April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Solid Biosciences.
Solid Biosciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Solid Biosciences.
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.